AGX shareholder files Rule 144 to sell 6,595 common shares

A holder of AGX common stock has filed a notice under Rule 144 to sell 6,595 shares through Morgan Stanley Smith Barney LLC on the NYSE, with an indicated aggregate market value of $2,068,918.11.

Rhea-AI Filing Summary

A holder of AGX common stock has filed a notice under Rule 144 to sell 6,595 shares through Morgan Stanley Smith Barney LLC on the NYSE, with an indicated aggregate market value of $2,068,918.11. The sale follows an exercise of stock options under a registered plan on 01/07/2026, paid in cash for the same number of shares.

The notice reports 13,873,410 common shares outstanding. It also lists recent sales for the same person over the past three months: 6,493 shares on 10/20/2025 for $1,911,329.25, 2,000 shares on 10/17/2025 for $584,000.00, and 4,000 shares on 01/07/2026 for $1,313,353.88. The seller represents that they are not aware of undisclosed material adverse information about the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many AGX shares are planned to be sold under this Rule 144 notice?

The notice covers the proposed sale of 6,595 shares of AGX common stock, with an indicated aggregate market value of $2,068,918.11.

How were the AGX shares in this Rule 144 filing acquired?

The 6,595 AGX common shares were acquired on 01/07/2026 through an exercise of options under a registered plan, with the purchase price paid in cash.

Through which broker and exchange will the AGX shares be sold?

The planned sale is through Morgan Stanley Smith Barney LLC Executive Financial Services, with the shares to be sold on the NYSE.

What is the total number of AGX shares outstanding referenced in this filing?

The filing states that the number of AGX common shares outstanding is 13,873,410.

What AGX share sales has the seller made in the past three months?

The notice lists three recent AGX common stock sales: 6,493 shares on 10/20/2025 for $1,911,329.25, 2,000 shares on 10/17/2025 for $584,000.00, and 4,000 shares on 01/07/2026 for $1,313,353.88.

What representation does the seller make about AGX in this Rule 144 filing?

The seller represents that they do not know of any material adverse information regarding the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/08/2026 - 04:17 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001627519
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ARGAN, INC.
SEC File Number	001-31756
Address of Issuer	4075 Wilson Boulevard Suite 440 Arlington VIRGINIA 22203
Phone	(301) 315-0027
Name of Person for Whose Account the Securities are To Be Sold	PETER W. GETSINGER
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6595	2068918.11	13873410	01/08/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/07/2026	Exercise of options under a registered plan	Issuer			6595	01/07/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
PETER W. GETSINGER 4075 Wilson Boulevard Suite 440 Arlington VA 22203	Common	10/20/2025	6493	1911329.25
PETER W. GETSINGER 4075 Wilson Boulevard Suite 440 Arlington VA 22203	Common	10/17/2025	2000	584000.00
PETER W. GETSINGER 4075 Wilson Boulevard Suite 440 Arlington VA 22203	Common	01/07/2026	4000	1313353.88

144: Remarks and Signature

Remarks
Date of Notice	01/08/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Peter Getsinger
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)